| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |